BBIO
BridgeBio Pharma, Inc. Common Stock
$67.58
0.42%
+0.28
Notify me if price changes either direction
Buy BBIO stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
13.2B
Enterprise value
14.7B
Trailing PE
-17.886243547712
Forward PE
204.38705
PEG Ratio
3.9349735804966
Enterprise to EBITDA
-29.564
Enterprise to revenue
25.431
Price to book MRQ
-5.8045264966383
Price to sales TTM
22.876898
Financials
Fiscal Year Ends
2025-12-31
Most Recent Quarter (MRQ)
2026-03-31
Revenue (TTM)
580.0M
EBITDA
-498881984
Diluted EPS TTM
-3.74
Total Cash (MRQ)
940.2M
Current ratio (MRQ)
1.521
Operating Cash Flow (TTM)
-443953984
BBIO trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
June 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
